D C Linehan1, W B Bowne, J J Lewis
1Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Advancements in identifying tumor antigens and understanding immune evasion have revitalized cancer immunotherapy. This review focuses on sarcoma, highlighting unique tumor-specific fusion proteins as promising targets for novel immune therapies and vaccine strategies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: